OTC • Last print unknown ago
$24.57—Stale · unknown old
Torii Pharmaceutical Co., Ltd. specializes in the development and manufacturing of specialty and generic pharmaceuticals, primarily focused on the Japanese market. The company differentiates itself through a robust pipeline of innovative therapies and a strong distribution network that enables it to capture a significant share of the growing healthcare sector in Japan.
Torii generates revenue through the sale of both specialty and generic drugs, leveraging its strong R&D capabilities to develop unique formulations that command premium pricing. The company benefits from a limited competitive landscape in certain therapeutic areas, allowing for higher margins and stable cash flows.
Approval of new drug applications in Japan
Changes in healthcare regulations affecting drug pricing
Market share gains in key therapeutic areas
Partnerships or collaborations with larger pharmaceutical companies
Regulatory changes impacting drug approval processes
Technological disruption in drug development and manufacturing
Increased competition from generic drug manufacturers
Potential entry of large multinational pharmaceutical companies into the Japanese market
Low liquidity risk due to high current ratio of 5.18
Potential risks associated with reliance on a limited number of key products
moderate - The pharmaceutical sector is somewhat insulated from economic downturns, but overall healthcare spending is linked to GDP growth and consumer confidence.
Low - The company has no debt, so rising interest rates do not directly impact financing costs. However, higher rates could influence healthcare spending indirectly.
minimal - The company operates with a zero debt level, reducing sensitivity to credit conditions.
growth - Investors looking for exposure to the growing pharmaceutical sector in Japan with potential for high returns from innovative drug launches.
moderate - The stock has experienced significant volatility, particularly with a recent 100% decline in returns over the past year.